[1] Kato T, Inubushi T, Kato N. Magnetic resonance spectroscopy in afective disorders[J]. J Neuropsychiatry Clin Neurosci 1998 Spring, 10:133

[2] Scarabino T, Popolizio T, Bertolino A, et al. Proton magnetic resonance spectroscopy of the brain in pediatric patients[J]. Eur J Radiol 1999,30:142

[3] Pan J W, Bebin E M, Chu W J, et al. Ketosis and epilepsy: ³¹P spectroscopic imaging at 4.1T[J]. Epilepsia 1999,40:703

[4] Huppi P S, Bames P D. Magnetic resonance techniques in the evaluation of the newborn brain[J]. Clin Perinatol, 1997,24:693

[5] Moesgaard B, Jaroszewski J W, Hansen H S. Accumulation of N-acyl-ethanolamine phospholipids in rat brains during post-decapitative ischemia:a ³¹P NMR study[J]. J Lipid Res, 1999,40:515

[6] Peeling J, Shoemaker L, Gauthier T, et al. Cerebral metabolic and histological effects of thioacetamide-induced liver failure[J], Am J Physiol, 1993,265:G572

[7] Glonek T, Kopp S J, Kot E, et al. ³¹P nuclear magnetic resonance analysis of brain:the perchloric acid extract spectrum[J]. J Neurochem, 1982,39:1210

[8] Kopp S J, Krieglstein J, Freidank A, et al. ³¹P nuclear magnetic resonance analysis of brain: Ⅱ.Effects of oxygen deprivation on isolated perfused and nonperfused rat brain[J]. J Neurochem, 1984,43:1716

[9] Kilby P M, Bolas N M, Radda G K. ³¹P NMR study of brain phospholipid structures in vivo[J]. Biochem Biophys Acta, 1991,1085:257

[10] Gyulai L, Bolinger L, Leigh J S Jr, et al. Phosphorylethanolamine the major constituent of the phosphomonoester peak observed by ³1P NMR on developing dog brain[J]. FEBS Lett, 1984,167:137

[11] Ponten U, Ratcheson R A, Salford L G, et al. Optimal freezing conditions for cerebral metabolites in rets[J]. J Neurochem, 1973,21:1127